FDA Inspection 1086726 — Egils Vjaters
The FDA completed an inspection of Egils Vjaters on March 28, 2019 in Riga. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 28, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Riga (Latvia)
Additional Details
Clinical Investigator (CI)